Eosinophils and Th2 immunity: Contemporary insights

Immunology and Cell Biology

Volumn 88, Issue 3, 2010, Pages 250-256

  Spencer, Lisa A ^a   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CHEMOKINE; EOSINOPHIL PROTEIN X; EOTAXIN; EOTAXIN 2; EOTAXIN 3; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RIBONUCLEASE A; TRANSCRIPTION FACTOR GATA 1;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BASOPHIL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL POLARITY; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE; NATURAL KILLER T CELL; REVIEW; SUPPRESSOR CELL; TH2 CELL;

ANIMALS; EOSINOPHILS; HELMINTHIASIS; HELMINTHS; HUMANS; IMMUNITY, CELLULAR; ORGAN SPECIFICITY; TH2 CELLS;

VERMES;

EID: 77949872807     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.115     Document Type: Review

References (80)

1. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-1174.
2. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
3. Hogan SP, Koskinen A, Foster PS. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 1997; 75: 284-288.
4. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003; 111: 227-242; quiz 43.
5. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24: 147-174.
6. Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 2002; 195: 1387-1395.
7. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305: 1773-1776.
8. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305: 1776-1779.
9. Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, Humbles A et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 2008; 205: 1285-1292.
10. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, Colbert DC et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 2008; 205: 699-710.
11. Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci USA 2006; 103: 16418-16423.
12. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002; 195: 1433-1444.
13. Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 2006; 203: 1435-1446.
14. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cellreceptor transgenic system. Proc Natl Acad Sci USA 1992; 89: 6065-6069.
15. Seder RA, Paul WE, Davis MM, Fazekas de St Groth B. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 1992; 176: 1091-1098.
16. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172: 921-929.
17. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189: 1565-1572.
18. Urban Jr JF, Noben-Trauth N, Schopf L, Madden KB, Finkelman FD. Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. J Immunol 2001; 167: 6078-6081.
19. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997; 185: 461-469.
20. Noben-Trauth N, Shultz LD, Brombacher F, Urban Jr JF, Gu H, Paul WE. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997; 94: 10838-10843.
21. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 2005; 174: 1063-1072.
22. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004; 20: 267-277.
23. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002; 420: 825-829.
24. Sabin EA, Pearce EJ. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J Immunol 1995; 155: 4844-4853.
25. Sabin EA, Kopf MA, Pearce EJ. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996; 184: 1871-1878.
26. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105: 945-953.
27. Shi HZ, Xiao CQ, Li CQ, Mo XY, Yang QL, Leng J et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 2004; 59: 428-435.
28. Duez C, Dakhama A, Tomkinson A, Marquillies P, Balhorn A, Tonnel AB et al. Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol 2004; 114: 820-825.
29. van Rijt LS, Vos N, Hijdra D, de Vries VC, Hoogsteden HC, Lambrecht BN. Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells. J Immunol 2003; 171: 3372-3378.
30. MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 2001; 167: 3146-3155.
31. Spencer LA, Szela CT, Perez SA, Kirchhoffer CL, Neves JS, Radke AL et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 2009; 85: 117-123.
32. Lacy P, Moqbel R. Eosinophil cytokines. Chem Immunol 2000; 76: 134-155.
33. Woerly G, Lacy P, Younes AB, Roger N, Loiseau S, Moqbel R et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 2002; 72: 769-779.
34. Lacy P, Mahmudi-Azer S, Bablitz B, Hagen SC, Velazquez JR, Man SF et al. Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. Blood 1999; 94: 23-32.
35. Lacy P, Moqbel R. Eokines: synthesis, storage and release from human eosinophils. Mem Inst Oswaldo Cruz 1997; 92(Suppl 2): 125-133.
36. Tedla N, Bandeira-Melo C, Tassinari P, Sloane DE, Samplaski M, Cosman D et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci USA 2003; 100: 1174-1179.
37. Liu LY, Bates ME, Jarjour NN, Busse WW, Bertics PJ, Kelly EA. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol 2007; 179: 4840-4848.
38. Schroeder JT. Basophils beyond effector cells of allergic inflammation. Adv Immunol 2009; 101: 123-161.
39. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, Liu YJ et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
40. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DCactivated Th2 memory cells. J Exp Med 2007; 204: 1837-1847.
41. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002; 196: 447-457.
42. Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 2003; 125: 1762-1773.
43. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002; 9: 1069-1077.
44. Odemuyiwa SO, Ghahary A, Li Y, Puttagunta L, Lee JE, Musat-Marcu S et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 2004; 173: 5909-5913.
45. Tulic MK, Sly PD, Andrews D, Crook M, Davoine F, Odemuyiwa SO et al. Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system. Am J Pathol 2009; 175: 2043-2052.
46. Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ. Eosinophilderived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 2003; 102: 3396-3403.
47. Yang D, Chen Q, Rosenberg HF, Rybak SM, Newton DL, Wang ZY et al. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol 2004; 173: 6134-6142.
48. Yang D, Chen Q, Su SB, Zhang P, Kurosaka K, Caspi RR et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 2008; 205: 79-90.
49. Mawhorter SD, Pearlman E, Kazura JW, Boom WH. Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi. Infect Immun 1993; 61: 5410-5412.
50. Del Pozo V, De Andres B, Martin E, Cardaba B, Fernandez JC, Gallardo S et al. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 1992; 22: 1919-1925.
51. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006; 74: 3232-3238.
52. Padigel UM, Hess JA, Lee JJ, Lok JB, Nolan TJ, Schad GA et al. Eosinophils act as antigen presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007; 196: 1844-1851.
53. Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007; 179: 7585-7592.
54. Loss Jr GE, Sant AJ. Invariant chain retains MHC II class molecules in the endocytic pathway. J Immunol 1993; 150: 3187-3197.
55. Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 1982; 79: 175-178.
56. Lucey DR, Nicholson-Weller A, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 1989; 86: 1348-1351.
57. Celestin J, Rotschke O, Falk K, Ramesh N, Jabara H, Strominger J et al. IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils. J Immunol 2001; 167: 6097-6104.
58. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996; 97: 1761-1766.
59. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol 2000; 23: 379-388.
60. Beninati W, Derdak S, Dixon PF, Grider DJ, Strollo DC, Hensley RE et al. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol 1993; 92: 442-449.
61. Hansel TT, Braunstein JB, Walker C, Blaser K, Bruijnzeel PL, Virchow Jr JC et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991; 86: 271-277.
62. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, McAllister PK, Busse WW. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992; 149: 3710-3718.
63. Mawhorter SD, Kazura JW, Boom WH. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology 1994; 81: 584-591.
64. Liu LY, Mathur SK, Sedgwick JB, Jarjour NN, Busse WW, Kelly EA. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy 2006; 61: 589-597.
65. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993; 150: 2554-2562.
66. Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Lee WM, Kelly EA et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998; 160: 1279-1284.
67. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004; 117: 515-526.
68. Liotta F, Frosali F, Querci V, Mantei A, Fili L, Maggi L et al. Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction. J Allergy Clin Immunol 2008; 121: 1000-1005 e8.
69. Maekawa Y, Tsukumo S, Chiba S, Hirai H, Hayashi Y, Okada H et al. Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003; 19: 549-559.
70. Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol 2009; 182: 7381-7388.
71. Okamoto M, Matsuda H, Joetham A, Lucas JJ, Domenico J, Yasutomo K et al. Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol 2009; 183: 2995-3003.
72. Radke A, Reynolds LE, Melo RCN, Dvorak AM, Weller PF, Spencer LA. Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation. Blood 2009; 113: 3092-3101.
73. Wong CK, Hu S, Cheung PF, Lam CW. TSLP induces chemotactic and pro-survival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 2009.
74. van Reijsen FC, Bruijnzeel-Koomen CA, de Weger RA, Mudde GC. Retention of longlived, allergen-specific T cells in atopic dermatitis skin-letter. J Invest Dermatol 1997; 108: 530.
75. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353: 196-200.
76. Mojtabavi N, Dekan G, Stingl G, Epstein MM. Long-lived Th2 memory in experimental allergic asthma. J Immunol 2002; 169: 4788-4796.
77. Neves JS, Perez SA, Spencer LA, Melo RC, Reynolds L, Ghiran I. et al. Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc Natl Acad Sci USA 2008; 105: 18478-18483.
78. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10: 713-720.
79. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y et al. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 2009; 10: 706-712.
80. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokinedependent immunity. Nat Immunol 2009; 10: 697-705.